REFERENCES

1. Renaudineau Y, Youinou P. Epigenetics and autoimmunity, with special emphasis on methylation. Keio J Med 2011;60:10-16.

2. Couce M, Dieguez C, Casanueva FF. Pituitary anatomy and physiology.

3. Adams JM, Taylor AE, Schoenfeld DA, et al. The midcycle gonado­tropin surge in normal women occurs in the face of an unchanging gonadotropin-releasing hormone pulse frequency. J Clin Endocrinol Metab 1994;79:858-64.

4. Hillier SG. Current concepts of the roles of follicle stimulating hor­mone and luteinizing hormone in folliculogenesis. Hum Reprod 1994;9:188-91.

5. Sherman BM, West JH, Korenman SG. The menopausal transi­tion: analysis of LH, FSH, estradiol, and progesterone concentra­tions during menstrual cycles of older women. J Clin Endocrinol Metab 1976;42:629-36.

6. Neer RM, SWAN Investigators. Bone loss across the menopausal transition. Ann N Y Acad Sci 2010;1192:66-71.

7. Van Voorhis BJ, Santoro N, Harlow S, et al. The relationship of bleeding patterns to daily reproductive hormones in women ap­proaching menopause. Obstet Gynecol 2008;112:101-8.

8. Woods NF, Mitchell ES. Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women’s Health Study. Sleep 2010;33:539-49.

9. Greendale GA, Ishii S, Huang MH, Karlamangla AS. Predicting the timeline to the final menstrual period: the study of women’s health across the nation. J Clin Endocrinol Metab 2013;98:1483-91.

10. Lopez-Ubeda R, Matas C. An approach to the factors related to sperm capacitation process. Andrology 2015;4:128.

11. Masters WH, Johnson VE. Human Sexual Response. Boston, MA: Little, Brown; 1966.

12. Kaplan H. Disorders of Sexual Desire. New York: Simon and Schuster; 1979.

13. Roberts JM, Escudero C. The placenta in preeclampsia. Pregnancy Hypertens 2012;2:72-83.

14. Ugwumadu A. Medical microbiology. In: Basic sciences for Obstetrics and Gynaecology, pp. 141-60. Oxford: Oxford University Press; 2014.

15. Horton R, Wilming L, Rand V, et al. Gene map of the extended human MHC. Nat Rev Genet 2004;5:889-99.

16. Schoeller DA. Changes in total body water with age. Am J Clin Nutr 1989;50 Suppl 5;1176-81.

17. Chumlea WC, Guo SS, Zeller CM, et al. Total body water ref­erence values and prediction equations for adults. Kidney Int 2001;59:2250-8.

18. Ritz P, Vol S, Berrut G, Tack I, Arnaud MJ, Tichet J. Influence of gender and body composition on hydration and body water spaces. Clin Nutr 2008;27:740-6.

19. Delaney A. Physiology of body fluids. In: Webb A, Angus D, Finfer F, Gattinoni L, Singer M (eds), Oxford Textbook of Critical Care, 2nd edn, pp. 304-7. Oxford: Oxford University Press; 2016.

20. Ball SG. Vasopressin and disorders of water balance: the physi­ology and pathophysiology of vasopressin. Ann Clin Biochem 2007;44:417-31.

21. Ugwumadu A. Endocrinology. In: Basic sciences for Obstetrics and Gynaecology, pp. 103-20. Oxford: Oxford University Press; 2014.

22. Preskorn SH, Hatt CR. How pharmacogenomics (PG) are chan­ging practice: implications for prescribers, their patients, and the healthcare system (PG series part I). J Psychiatr Pract 2013; 19: 142-9.

23. Rubin P. Prescribing in pregnancy. In: Warrell DA, Cox TM, Firth JD (eds) Oxford Textbook of Medicine, 5th edn, pp. 2186-90. Oxford: Oxford University Press; 2010.

24. CLASP Collaborative Group. Low dose aspirin in pregnancy and early childhood development: follow up of the collabora­tive low dose aspirin study in pregnancy. Br J Obstet Gynaecol 1995;102:861-8.

25. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose as­pirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994;343:619-29.

26. Buhimschi CS, Weiner CP. Medications in pregnancy and lacta­tion: part 1. Teratology. Obstet Gynecol 2009;113:166-88.

27. Buhimschi CS, Weiner CP. Medications in pregnancy and lacta­tion: part 2. Drugs with minimal or unknown human teratogenic effect. Obstet Gynecol 2009;113:417-32.